Kobe, Japan

Chihiro Shindoh

This inventor holds 1 USPTO granted patent. Top assignee: Jcr Pharmaceuticals Co., Ltd.. Active years: 1998.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chihiro Shindoh: Innovator in Platelet Factor-4 Recovery

Introduction

Chihiro Shindoh is a notable inventor based in Kobe, Japan. She has made significant contributions to the field of biochemistry, particularly in the recovery of platelet factor-4. Her innovative approach has the potential to enhance production processes in the pharmaceutical industry.

Latest Patents

Chihiro Shindoh holds a patent for a process titled "Process for obtaining platelet factor-4." This invention utilizes readily available sulfated chitin as an adsorbent, allowing for the recovery of platelet factor-4 through specific adsorption from a solution. This method significantly increases yields compared to conventional processes that use heparin-immobilized affinity columns. The advantages of her process include the use of more accessible materials, a simplified procedure, and improved production yields, making it suitable for commercial-scale mass production.

Career Highlights

Chihiro Shindoh is associated with JCR Pharmaceuticals Co., Ltd., where she applies her expertise in biochemistry to advance innovative solutions. Her work has garnered attention for its practical applications in the pharmaceutical sector.

Collaborations

Chihiro has collaborated with esteemed colleagues, including Yoshikazu Komurasaki and Takashi Hirose. These partnerships have contributed to the development and refinement of her innovative processes.

Conclusion

Chihiro Shindoh's contributions to the recovery of platelet factor-4 exemplify the impact of innovation in the pharmaceutical industry. Her work not only enhances production efficiency but also opens new avenues for research and development.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…